Showing results (781-790 of 804) with videos related to

Sort By:
Pageof 81
The Lancet. Gastroenterology & Hepatology|November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2019
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantationMassimo Iavarone, Federica Invernizzi, Carolin Czauderna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world dataClaudia Campani, Ju Hyun Shim, Mohamed Bouattour, et al.
Kidney International Reports|February 23, 2026
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor NephritisIdris Boudhabhay, Helene Lazareth, Julie Oniszczuk, et al.
JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinomaAnne Victoire Odent, Claudia Campani, Mohamed Bouattour, et al.
The British Journal of Dermatology|October 29, 2024
Biologics in congenital ichthyosis: are they effective?Juliette Mazereeuw-Hautier, Céline Granier Tournier, Angela Hernandez-Martin, et al.
JAMA|February 8, 2018
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO ExtensionMelanie Calvert, Derek Kyte, Rebecca Mercieca-Bebber, et al.
Pageof 81